7CGW
Complex structure of PD-1 and tislelizumab Fab
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | SSRF BEAMLINE BL17U1 |
Synchrotron site | SSRF |
Beamline | BL17U1 |
Temperature [K] | 93 |
Detector technology | PIXEL |
Collection date | 2018-06-20 |
Detector | DECTRIS EIGER X 16M |
Wavelength(s) | 0.979 |
Spacegroup name | C 2 2 21 |
Unit cell lengths | 142.638, 145.572, 175.549 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 101.880 - 3.200 |
R-factor | 0.2203 |
Rwork | 0.218 |
R-free | 0.25400 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | Tislelizumab Fab |
RMSD bond length | 0.006 |
RMSD bond angle | 1.095 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHENIX |
Refinement software | PHENIX (1.17.1_3660) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 101.880 | 3.370 |
High resolution limit [Å] | 3.200 | 3.200 |
Number of reflections | 30470 | 4399 |
<I/σ(I)> | 11.8 | 2.4 |
Completeness [%] | 99.9 | |
Redundancy | 11.4 | |
CC(1/2) | 0.994 | 0.673 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 4 | 293 | 0.1M Citric acid, pH4.0, 1M LiCl and 20% PEG6000 |